Sinus stent for chronic sinusitis trial
Part of Ear, nose & throat clinical trials.
This study tests a new sinus stent that slowly releases medicine to treat chronic sinusitis in both nostrils. The goal is to see if it helps reduce symptoms and inflammation better than usual care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have chronic sinusitis in both nostrils, confirmed by a CT scan showing a specific score higher than 6
- If you are female and can get pregnant, you agree not to become pregnant or breastfeed for one year after the procedure
- You have not joined another research study in the last 3 months
- You are not allergic to any of the materials in the sinus stent (like mometasone, polylactic acid, etc.)
- You do not have certain eye conditions (glaucoma, high eye pressure, cataracts, artificial eye) or diabetes; and you are not on long-term hormone medications or immune-weakening drugs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special nose dressing that slowly releases a steroid to reduce inflammation and improve healing after sinus surgery for chronic sinusitis with or without nasal polyps.
This study tests a steroid-releasing implant placed during sinus surgery to help prevent inflammation and improve healing in patients with chronic sinus infections. If you're having sinus surgery in Japan, this trial may track how well the implant works for you.
This trial tests a nasal spray called VVN432 in healthy volunteers and people with chronic sinusitis. It checks if the spray is safe and how the body processes it.
This study tests two treatments for chronic sinusitis: one uses sound waves to deliver a steroid (dexamethasone) through the skin, and the other uses laser acupuncture. It aims to see which works better for reducing symptoms like congestion, facial pain, and reduced sense of smell.
This trial tests a fully dissolvable stent that releases medication inside the sinuses after surgery. It is for patients with a specific type of sinusitis (eosinophilic) and nasal polyps who either need surgery or have had surgery and show early signs of inflammation returning.
This trial tests an experimental tablet (HTMC0658) for people with chronic sinusitis that hasn't improved with standard nasal spray. You may join if your symptoms are moderate to severe and you've been using a stable dose of mometasone spray for at least 4 weeks.
Hear when a new Chronic Rhinosinusitis (CRS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.